VMS symptoms and cardiovascular implications

Video

Rebecca Thurston, PhD, sits down to discuss her research presented at the NAMS Annual Meeting on vasomotor symptoms and cardiovascular health.

In an exclusive video interview, Rebecca Thurston, PhD, sits down with Contemporary OB/GYN® Managing Editor Morgan Petronelli to discuss her presentations from the North American Menopause Society's (NAMS) Annual Meeting held recently in Atlanta, Georgia, from October 12-15.

Thurston is the chair of the Pittsburgh Foundation; a professor of psychiatry, psychology, and epidemiology at the University of Pittsburgh where she directs the Women's Behavioral Health program; and is the NAMS 2022 Scientific program chair.

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.